Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Loris De Cecco

Showing results (111-120 of 169) with videos related to

Pageof 17
Sort By:
Cancer Letters|December 24, 2022
Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressivenessGiancarla Bernardo, Valentino Le Noci, Emerenziana Ottaviano, et al.
Scientific Reports|June 7, 2024
Impact of in vitro SARS-CoV-2 infection on breast cancer cellsMichele Sommariva, Maria Dolci, Tiziana Triulzi, et al.
Cancer Medicine|March 20, 2015
Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtypeXiaoyan Huang, Matteo Dugo, Maurizio Callari, et al.
Genes|September 28, 2021
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma PatientsElisabetta Vergani, Simona Frigerio, Matteo Dugo, et al.
Cancer Research|January 23, 2021
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast CancerMartina Di Modica, Giorgio Gargari, Viola Regondi, et al.
Oral Oncology|August 9, 2025
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disordersCristina Gurizzan, Armando G Licata, Luigi Lorini, et al.
Scientific Reports|January 31, 2024
A gene expression-based classifier for HER2-low breast cancerSerena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, et al.
Iscience|September 12, 2024
Widening the spectrum of players affected by genetic changes in Wilms tumor relapseSara Ciceri, Alessia Bertolotti, Annalisa Serra, et al.
BMC Cancer|May 18, 2021
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trialCristina Gurizzan, Luigi Lorini, Alberto Paderno, et al.
Journal of Cellular and Molecular Medicine|June 23, 2017
Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injuryMarilena Gregorini, Valeria Corradetti, Eleonora Francesca Pattonieri, et al.
Pageof 17

Showing results (111-120 of 169) with videos related to

Sort By:
Pageof 17
Cancer Letters|December 24, 2022
Reduction of Staphylococcus epidermidis in the mammary tumor microbiota induces antitumor immunity and decreases breast cancer aggressivenessGiancarla Bernardo, Valentino Le Noci, Emerenziana Ottaviano, et al.
Scientific Reports|June 7, 2024
Impact of in vitro SARS-CoV-2 infection on breast cancer cellsMichele Sommariva, Maria Dolci, Tiziana Triulzi, et al.
Cancer Medicine|March 20, 2015
Molecular portrait of breast cancer in China reveals comprehensive transcriptomic likeness to Caucasian breast cancer and low prevalence of luminal A subtypeXiaoyan Huang, Matteo Dugo, Maurizio Callari, et al.
Genes|September 28, 2021
Genetic Variants and Somatic Alterations Associated with MITF-E318K Germline Mutation in Melanoma PatientsElisabetta Vergani, Simona Frigerio, Matteo Dugo, et al.
Cancer Research|January 23, 2021
Gut Microbiota Condition the Therapeutic Efficacy of Trastuzumab in HER2-Positive Breast CancerMartina Di Modica, Giorgio Gargari, Viola Regondi, et al.
Oral Oncology|August 9, 2025
The interplay of hypoxia, inflammation, and microbiota as indicators of malignant transformation in oral potentially malignant disordersCristina Gurizzan, Armando G Licata, Luigi Lorini, et al.
Scientific Reports|January 31, 2024
A gene expression-based classifier for HER2-low breast cancerSerena Di Cosimo, Sara Pizzamiglio, Chiara Maura Ciniselli, et al.
Iscience|September 12, 2024
Widening the spectrum of players affected by genetic changes in Wilms tumor relapseSara Ciceri, Alessia Bertolotti, Annalisa Serra, et al.
BMC Cancer|May 18, 2021
Immunotherapy for the prevention of high-risk oral disorders malignant transformation: the IMPEDE trialCristina Gurizzan, Luigi Lorini, Alberto Paderno, et al.
Journal of Cellular and Molecular Medicine|June 23, 2017
Perfusion of isolated rat kidney with Mesenchymal Stromal Cells/Extracellular Vesicles prevents ischaemic injuryMarilena Gregorini, Valeria Corradetti, Eleonora Francesca Pattonieri, et al.
Pageof 17